Research Topics
Genomes and Genes | Nicholas ChiorazziSummaryAffiliation: North Shore University Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Implications of new prognostic markers in chronic lymphocytic leukemiaNicholas Chiorazzi
The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, NY, USA
Hematology Am Soc Hematol Educ Program 2012:76-87. 2012..These and other biology-based indicators of patient clinical course and outcome can be used as starting points from which to understand and treat CLL...
Enhanced expression of mRNA for nuclear factor kappaB1 (p50) in CD34+ cells of the bone marrow in rheumatoid arthritisShunsei Hirohata
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo 173 8605, Japan
Arthritis Res Ther 8:R54. 2006..These results indicate that the enhanced expression of NFkappaB1 mRNA in bone marrow CD34+ cells plays a pivotal role in their abnormal responses to TNF-alpha and, thus, in the pathogenesis of RA...
Chronic lymphocytic leukemiaNicholas Chiorazzi
Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY 11030, USA
N Engl J Med 352:804-15. 2005
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilitiesNicholas Chiorazzi
Feinstein Institute for Medical Research and Department of Medicine, North Shore University Hospital and Albert Einstein College of Medicine, Manhasset, NY 11030, USA
Blood 117:1781-91. 2011....
B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigensNicholas Chiorazzi
Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Community Drive, Manhasset, NY 11030, USA
Ann N Y Acad Sci 1062:1-12. 2005..Thus, B-CLL appears to be a disease of B-cell clones that have undergone various types of receptor reconfiguration and yet retain inappropriate antigen-binding properties...
Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cellsNicholas Chiorazzi
The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
Best Pract Res Clin Haematol 20:399-413. 2007..Therefore, CLL is a disease of both proliferation and accumulation in which a homeostatic balance exists in patients with stable lymphocyte counts or an imbalance exists in patients with rising lymphocyte counts...
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptorNicholas Chiorazzi
North Shore Long Island Jewish Research Institute, Manhasset, New York 11030, USA
Annu Rev Immunol 21:841-94. 2003..Finally, we discuss current and emerging views of the cellular origin of B-CLL cells and the differentiation pathways down which we believe these cells progress...
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemiaCarlo Calissano
The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY, USA
Blood 114:4832-42. 2009....
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cellsCarlo Calissano
The Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, New York, United States of America
Mol Med 17:1374-82. 2011..Finally, the study lays the groundwork for future analyses that might provide a more robust understanding of the development and clonal evolution of this currently incurable disease...
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu
The Feinstein Institute for Medical Research, North Shore Long Island Jewish LIJ Health System, Manhasset, NY 11030, USA
Blood 115:3907-15. 2010..Taken together, our data indicate that a large proportion of CLL clones emerge from natural antibody-producing cells expressing immunoglobulins that recognize MEACs, and that this reactivity is associated with poor clinical outcome...
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patientsRajendra N Damle
Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY 11030, USA
Blood 120:2438-49. 2012..These findings provide an understanding of how BCR-mediated signals impact telomerase modulation in IGHV mutation-based subgroups of B-CLL and normal B cells...
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemiaFabio Ghiotto
Department of Medicine, North Shore University Hospital, Manhasset, NY, USA
Mol Med 12:300-8. 2006..These similarities and differences between the IgH and IgL V gene repertoires expressed in B-CLL suggest some novel features while also reinforcing concepts derived from studies of the IgH repertoire...
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation statusDavorka Messmer
The Laboratory of Experimental Immunology, Institute for Medical Research, North Shore LIJ Health System, Manhasset, New York, USA
Mol Med 10:96-103. 2004..Our data show that DCs generated from the B-CLL subgroup with unmutated Ig V genes are functionally normal. These results are very promising for the use of DCs from patients with poor prognosis for immunotherapy...
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIACharles C Chu
The Feinstein Institute for Medical Research, North Shore Long Island Jewish LIJ Health System, Manhasset, NY, USA
Blood 112:5122-9. 2008..Binding of CLL mAb to MYHIIA could promote the development, survival, and expansion of these leukemic cells...
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cellsRajendra N Damle
Laboratory of Experimental Immunology, The Feinstein Institute for Medical Research, North Shore Long Island Jewish LIJ Health System, 350 Community Drive, Manhasset, NY 11030, USA
Blood 110:3352-9. 2007..These findings may help explain why high percentages of CD38(+) cells within clones are associated with poor clinical outcome...
Dendritic cell activating peptides induce distinct cytokine profilesGloria Telusma
The Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY 11030, USA
Int Immunol 18:1563-73. 2006..These DC-activating peptides could serve as an adjuvant in immunotherapeutic or vaccine context and the selective activity of these different peptides suggests a means to customize the functional properties of DCs...
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemiaBradley T Messmer
North Shore-LIJ Research Institute, 350 Community Dr, Manhasset, NY 11030, USA
J Exp Med 200:519-25. 2004..These shared, stereotyped Ig molecules may be valuable probes for antigen identification and important targets for cross-reactive idiotypic therapy...
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao Jie Yan
The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY, USA
Blood 118:5201-10. 2011..These findings indicate the value of multicytokine analyses for prognosis and suggest therapeutic strategies in CLL aimed at reducing CL1 and increasing CL2/CL3 cytokines...
A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansionHyunjoo Lee
Laboratory of B Cell Biology, Karches Center for Chronic Lymphocytic Leukemia Research, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
J Immunol 188:6093-108. 2012....
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cellsTill Seiler
The Feinstein Institute for Medical Research, North Shore Long Island Jewish LIJ Health System, Manhasset, NY 11030, USA
Blood 114:3615-24. 2009....
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara
The Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Community Drive, Manhasset, NY 11030, USA
Blood 117:5463-72. 2011....
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutationsRajendra N Damle
North Shore-Long Island Jewish Research Institute, 350 Community Dr, Manhasset, NY 11030, USA
Blood 103:375-82. 2004..In addition, they reinforce the concept that B-CLL is not simply an accumulative disease of slowly dividing B lymphocytes but possibly one of B cells with extensive proliferative histories...
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten
The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY 11030, USA
Blood 120:4802-11. 2012..Furthermore, AID protein was associated with worse patient outcome and adverse cytogenetics. We conclude that the production of fully functional AID protein by U-CLL and M-CLL cells could be involved in clonal evolution of the disease...
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the cloneEmilia Albesiano
North Shore Long Island Jewish Research Institute, 350 Community Dr, Manhasset, NY 11030, USA
Blood 102:3333-9. 2003..These data suggest that AID-mediated DNA alterations may occur in a variably sized, minor subset of B-CLL cells at any given time...
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy
Laboratory of Experimental Immunology, The Feinstein Institute for Medical Research, Manhasset, New York 11030, USA
Mol Med 14:618-27. 2008..It is not clear if this surface membrane expression is a passive consequence of the apoptotic process or an active attempt by the B cell to abort cell death by stabilizing the plasma membrane...
Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockadesXiao Jie Yan
The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
Clin Immunol 131:481-94. 2009..Our studies suggest immunological mechanisms by which I3C ameliorates SLE in mice and provide a rationale for its use as an adjunctive therapy for human lupus...
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemiaFabio Ghiotto
Department of Medicine, North Shore University Hospital and New York University School of Medicine, Manhasset, New York, USA
J Clin Invest 113:1008-16. 2004....
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsBradley T Messmer
Institute for Medical Research, North Shore-LIJ Research Institute, Manhasset, New York 11030, USA
J Clin Invest 115:755-64. 2005..A correlation between birth rates and disease activity and progression appears to exist, which may help identify patients at risk for worsening disease in advance of clinical deterioration...
High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarizationDavorka Messmer
Laboratory of Experimental Immunology, North Shore LIJ Research Institute, 350 Community Drive, Manhasset, NY 11030, USA
J Immunol 173:307-13. 2004..HMGB1 released by necrotic cells may be a signal of tissue or cellular injury that, when sensed by DCs, induces and/or enhances an immune reaction...
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesRajendra N Damle
North Shore-Long Island Jewish Research Institute, Manhasset, NY 11030, USA
Blood 99:4087-93. 2002....
Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia veraCharles C Chu
The Feinstein Institute for Medical Research, North Shore Long Island Jewish LIJ Health System, Manhasset, New York, United States of America
Mol Med 17:1338-48. 2011..These results prove that this method identifies infectious agents and provides an experimental methodology to test correlation with disease...
The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation processBradley T Messmer
North Shore Long Island Jewish Research Institute, 350 Community Dr, Manhasset, NY 11030, USA
Blood 103:3490-5. 2004..60; framework region [FR] R/S, 1.72). These results are consistent with the notion that V(H) mutations in B-CLL cells result from canonical SHM and select for altered, structurally sound antigen receptors...
Chronic lymphocytic leukaemia: a disease of activated monoclonal B cellsRajendra N Damle
The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
Best Pract Res Clin Haematol 23:33-45. 2010....
A cyclooxygenase-2/prostaglandin E2 pathway augments activation-induced cytosine deaminase expression within replicating human B cellsHyunjoo Lee
Laboratory of B Cell Biology, Karches Center for Chronic Lymphocytic Leukemia Research, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
J Immunol 185:5300-14. 2010..Taken together, the results suggest that a PGE(2) feed-forward mechanism for augmenting COX-2 pathway proteins promotes progressively increased levels of AID mRNA, protein, and function...
Lifespan is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinolKaren J Auborn
North Shore Long Island Jewish Research Institute, Manhasset, NY 11030, USA
J Nutr 133:3610-3. 2003..The estrogen urinary metabolite ratio of 2- to 16alpha-hydroxyestrone was increased in I3C-fed mice. These findings demonstrate a profound effect of dietary I3C in experimental SLE...
Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatographyDorothy Guzowski
North Shore LIJ Research Institute, 350 Community Drive, Manhasset, New York 11030, USA
J Biomol Tech 16:154-66. 2005..Once distinct chromatograms were established for each of the SNPs and the nucleotide changes confirmed by sequencing, genotype and haplotype frequencies were tabulated for the groups studied...
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain
The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
Haematologica 97:599-607. 2012..The objective of this study was to quantify blood and tissue levels of Th17 and other interleukin-17-producing cells in patients with this disease and correlate blood levels with clinical outcome...
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera
Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, New York 11030, USA
Mol Med 14:665-74. 2008..These data suggest that CLL may derive from normal B cells whose function is to remove cellular debris, and also to provide a first line of defense against pathogens...
Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletionYasushi Miura
Center for Immunology and Inflammation, North Shore-LIJ Research Institute, Manhasset, NY 11030, USA
Mol Med 9:166-74. 2003..Thus, nucleotide insertion/deletion can lead to B-cell receptor diversification in B lymphocytes that clonally expand in synovial tissues of patients with rheumatoid arthritis...
Chronic lymphocytic leukemia: A tale of one or two signals?Nicholas Chiorazzi
Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Hofstra North Shore LIJ School of Medicine, 350 Community Drive, Manhasset, NY 10030, USA
Cell Res 23:182-5. 2013..These findings are discussed in the context of available information about the antigen reactivity of CLL B cells and its potential role in clonal survival and drive...
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cellsDavorka Messmer
Laboratory of Experimental Immunology, North Shore Long Island Jewish Research Institute, Manhasset, NY 11030, USA
Int Immunol 15:491-503. 2003..Since some of these genes have down-regulatory functions in other settings, they may have a regulatory role in DC maturation and immune response generation...
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaXiao Jie Yan
The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY 11030, USA
Proc Natl Acad Sci U S A 103:11713-8. 2006..This (auto)antigen-driven mouse model reliably captures the BCR characteristics of aggressive, treatment-resistant human B-CLL...
TSP50, a possible protease in human testes, is activated in breast cancer epithelial cellsJidong Shan
Department of Molecular Oncology, North Shore Long Island Jewish Research Institute, New York University School of Medicine, Manhasset, New York 11030, USA
Cancer Res 62:290-4. 2002....
CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 miceJuergen Foell
Department of Surgery and Emory Vaccine Center, School of Medicine, School of Public Health, Emory University, Atlanta, Georgia, USA
J Clin Invest 111:1505-18. 2003..Our data support the hypothesis that CD137-mediated signaling anergized CD4(+) T cells during priming at the DC interface...
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivityMaxime Hervé
Laboratory of Biochemistry and Molecular Immunology, Hospital for Special Surgery, New York, New York 10021, USA
J Clin Invest 115:1636-43. 2005..We concluded that both UM-CLLs and M-CLLs originate from self-reactive B cell precursors and that SHM plays an important role in the development of the disease by altering original BCR autoreactivity...
B lymphocytes in humans express ZAP-70 when activated in vivoGiovanna Cutrona
Division of Medical Oncology C, Istituto Nazionale per la Ricerca sul Cancro, IST, Genova, Italy
Eur J Immunol 36:558-69. 2006..B-CLL cells are activated cells and their ZAP-70 expression reflects a normal property of activated B cells populations rather than a neoplastic aberration...
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaFu Jun Li
Division of Hematology Oncology, Department of Medicine, University of Alabama at Birmingham, AL 35294 2182, USA
Blood 112:179-87. 2008..75 years for FCRL2-low patients. Our studies indicate that FCRL2 has robust predictive value for determining IGHV gene mutation status and clinical progression and thus may further improve prognostic definition in CLL...
Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell linesJulia Kurth
Institute for Genetics and Department of Internal Medicine I, University of Cologne, Cologne, Germany
Eur J Immunol 32:3785-92. 2002..We conclude that CD95 gene mutations play little if any role in the generation of the pool of PB in SLE patients and that mutations in the CD95 gene are rare among autoantibody-producing B cells in SLE and rheumatoid arthritis...
The human marginal zone B cellMariella Dono
Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, IST, Genova, Italy
Ann N Y Acad Sci 987:117-24. 2003..If the current distinction into B1 and B2 cells has to be maintained also for humans, it is likely that only these CD5-positive cells rather than the FM B cells should be called B1 cells...
Determining the clinical course and outcome in chronic lymphocytic leukemiaKanti R Rai
N Engl J Med 348:1797-9. 2003
Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patientsMonica Colombo
U O Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
Eur J Immunol 33:3433-8. 2003....
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemiaManlio Ferrarini
Division of Medical Oncology C, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
Semin Hematol 41:207-23. 2004..The difference in the ability to respond to antigen as a full-fledged B-CLL probably accounts for the different biological features and clinical outcomes of the patients in these subgroups...
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cellsElizabeth P Ryan
Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Clin Immunol 120:76-90. 2006..It will therefore be important to evaluate drugs that inhibit Cox-2 as potential therapeutic agents in B-CLL in vivo...
The CD38 ectoenzyme family: advances in basic science and clinical practiceFortunato Morabito
Unità Operativa di Ematologia, Azienda Ospedaliera di Cosenza, Cosenza, Italy
Mol Med 12:342-4. 2006....
Colocalization of antigen-specific B and T cells within ectopic lymphoid tissue following immunization with exogenous antigenJason S Weinstein
Division of Rheumatology and Clinical Immunology and Center for Autoimmune Disease, University of Florida, Gainesville, FL 32610, USA
J Immunol 181:3259-67. 2008..This has implications for understanding the strong association of humoral autoimmunity with lymphoid neogenesis, which may be associated with deficient censoring of autoreactive cells...
CD5+ B cells with the features of subepithelial B cells found in human tonsilsMariella Dono
S C Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
Eur J Immunol 37:2138-47. 2007..These data are discussed considering the present views on the origin of B cell subset populations and the relationships between MZ and B1 cells...
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsGiovanna Cutrona
PhD Divisione di Oncologia Medica C Istituto Nazionale per la Ricerca sul Cancro, IST, L go Rosanna Benzi, 10 16132 Genoa, Italy
Haematologica 93:413-22. 2008..We studied whether cells expressing CD38 and ZAP-70 are more susceptible to stimulation through B-cell receptors than are cells that do not express CD38 and ZAP-70...
Research Grants
- B-cell repertoires in chronic lymphocytic leukemiaNicholas Chiorazzi; Fiscal Year: 2009..The studies lay the groundwork for future therapies which will target the stimulants or the molecules on the leukemia cells that the stimulants bind. ..
- GENERAL CLINICAL RESEARCH CENTERNicholas Chiorazzi; Fiscal Year: 2006..The Interfacility Transport Division provides transportation of patients from hospital ..
- B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSIONNicholas Chiorazzi; Fiscal Year: 2004..Hopefully, these differences will provide important basic and clinical insights into this disease and suggest future prognostic and therapeutic approaches to it. ..
- B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIANicholas Chiorazzi; Fiscal Year: 2004..We anticipate that these studies will support a clonal evolution model proceeding from antigenically overexpanded normal aging B cells to a leukemic CCL clone. ..
- IRB Oversight and Educational Enhancement ProgramNicholas Chiorazzi; Fiscal Year: 2002..The new database will also keep track of education and training information and permit cross-referencing of serious adverse events. ..
- B-cell repertoires in chronic lymphocytic leukemiaNicholas Chiorazzi; Fiscal Year: 2010..The studies lay the groundwork for future therapies which will target the stimulants or the molecules on the leukemia cells that the stimulants bind. ..
